helenalin has been researched along with cd 437 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chung, LW; Jin, F; Khuri, FR; Liu, X; Lotan, R; Sun, SY; Yue, P; Zhou, Z | 1 |
1 other study(ies) available for helenalin and cd 437
Article | Year |
---|---|
Activation of nuclear factor-kappaB contributes to induction of death receptors and apoptosis by the synthetic retinoid CD437 in DU145 human prostate cancer cells.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Caspase 8; Caspases; Cell Line, Tumor; Humans; I-kappa B Proteins; Male; NF-kappa B; NF-KappaB Inhibitor alpha; Prostatic Neoplasms; Receptors, TNF-Related Apoptosis-Inducing Ligand; Receptors, Tumor Necrosis Factor; Retinoids; Sesquiterpenes; Sesquiterpenes, Guaiane; Up-Regulation | 2005 |